Tempus AI Future Growth
Future criteria checks 2/6
Tempus AI is forecast to grow earnings and revenue by 66.6% and 23.7% per annum respectively. EPS is expected to grow by 83.4% per annum. Return on equity is forecast to be -151.7% in 3 years.
Key information
66.6%
Earnings growth rate
83.4%
EPS growth rate
| Life Sciences earnings growth | 18.4% |
| Revenue growth rate | 23.7% |
| Future return on equity | -151.7% |
| Analyst coverage | Good |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Tempus AI: Pioneering The Future Of Precision Medicine Through AI-Driven Innovation
Nov 12Tempus: Attempting To Lead The AI Revolution In Healthcare
Oct 29Tempus AI: Deploying AI In Precision Medicine; Initiate With 'Buy'
Aug 21Tempus AI: Healthcare AI Play Faces Some Challenges From The Start
Jun 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,184 | -159 | 48 | 67 | 6 |
| 12/31/2025 | 915 | -243 | -39 | -29 | 9 |
| 12/31/2024 | 699 | -767 | -156 | -153 | 9 |
| 9/30/2024 | 640 | -801 | -207 | -190 | N/A |
| 6/30/2024 | 596 | -790 | -325 | -292 | N/A |
| 3/31/2024 | 562 | -293 | -284 | -249 | N/A |
| 12/31/2023 | 532 | -266 | -249 | -214 | N/A |
| 9/30/2023 | 485 | -276 | -266 | -233 | N/A |
| 12/31/2022 | 321 | -334 | -187 | -168 | N/A |
| 9/30/2022 | 293 | -325 | -192 | -173 | N/A |
| 12/31/2021 | 258 | -298 | -224 | -212 | N/A |
| 9/30/2021 | 285 | -296 | -205 | -193 | N/A |
| 6/30/2021 | 284 | -286 | -199 | -188 | N/A |
| 3/31/2021 | 236 | -270 | -209 | -198 | N/A |
| 12/31/2020 | 188 | -254 | -220 | -207 | N/A |
| 12/31/2019 | 62 | -148 | -134 | -117 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TEM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TEM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TEM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TEM's revenue (23.7% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: TEM's revenue (23.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TEM is forecast to be unprofitable in 3 years.